Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Dificid

02 2Dificlir

PharmaCompass

01

Brand Name : Dificid

Fidaxomicin

arrow
Antibody Engineering
Not Confirmed

Brand Name : Dificid

arrow
Antibody Engineering
Not Confirmed

Fidaxomicin

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2022 Revenue in Millions : 263

2021 Revenue in Millions : 175

Growth (%) : 50

blank

02

Brand Name : Dificid

Fidaxomicin

arrow
Antibody Engineering
Not Confirmed

Brand Name : Dificid

arrow
Antibody Engineering
Not Confirmed

Fidaxomicin

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2023 Revenue in Millions : 302

2022 Revenue in Millions : 263

Growth (%) : 15

blank

03

Brand Name : Dificlir

Fidaxomicin

arrow
Antibody Engineering
Not Confirmed

Brand Name : Dificlir

arrow
Antibody Engineering
Not Confirmed

Fidaxomicin

Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

Currency : USD

2016 Revenue in Millions : 20

2015 Revenue in Millions : 23

Growth (%) : -12

blank

04

Brand Name : Dificlir

Fidaxomicin

arrow
Antibody Engineering
Not Confirmed

Brand Name : Dificlir

arrow
Antibody Engineering
Not Confirmed

Fidaxomicin

Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

Currency : USD

2017 Revenue in Millions : 0

2016 Revenue in Millions : 21

Growth (%) : -100

blank